A Comparison of Saquinavir Hard- and Soft-Gelatin Capsules in HIV-Infected Patients

A Phase IIIB Open-Label, Comparative Study to Evaluate Saquinavir Soft Gel Capsule (SGC) Treatment in Combination With Other Antiretrovirals in HIV-1 Infected Antiretroviral-Naive Patients

NCT00002178 ·Status: COMPLETED ·Phase: PHASE3

Safety and Effectiveness of Adding Saquinavir (FORTOVASE) in Soft Gel Capsule Form to an Anti-HIV Drug Combination in HIV-Infected Patients

NCT00002229 ·Status: COMPLETED ·Phase: PHASE4

The Safety and Effectiveness of Two Forms of Saquinavir Combined With Other Anti-HIV Drugs in HIV-Infected Infants and Children

NCT00002380 ·Status: COMPLETED ·Phase: PHASE1

A Study to Compare Two Anti-HIV Drug Combinations

NCT00002447 ·Status: COMPLETED ·Phase: PHASE3

A Study of Ritonavir-Boosted Invirase (Saquinavir) in Treatment-Naïve HIV-1 Infected Patients

NCT01638650 ·Status: COMPLETED ·Phase: PHASE1

A Study to Compare the Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients

NCT00002448 ·Status: COMPLETED ·Phase: PHASE3

A Study to Compare Two Anti-HIV Combination Therapies Each Containing Saquinavir in HIV-Positive Children

NCT00000913 ·Status: COMPLETED ·Phase: PHASE2

A Study of Saquinavir Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients

NCT00002382 ·Status: COMPLETED ·Phase: PHASE3

A Randomized, Parallel Arm, Comparative, Open Label, Multicenter Study of the Activity and Safety of Two Formulations of Saquinavir in Combination With Other Antiretroviral Drugs

NCT00002162 ·Status: COMPLETED ·Phase: PHASE2

A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected Patients

NCT00001094 ·Status: WITHDRAWN ·Phase: PHASE2

A Phase II Open-Label Exploratory Study of Saquinavir + Zidovudine + Lamivudine in HIV Infected Patients

NCT00002190 ·Status: COMPLETED ·Phase: PHASE2

A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir

NCT00000892 ·Status: COMPLETED ·Phase: NA

Safety and Effectiveness Study of a Candidate Vaginal Microbicide for Prevention of HIV

NCT00441298 ·Status: COMPLETED ·Phase: PHASE2

A Relative Bioavailability and Food-Effect Study of GSK3640254 Tablet and Capsule Formulations in Healthy Participants

NCT04128293 ·Status: TERMINATED ·Phase: PHASE1

Phase I Trial of S-1153 in Patients With HIV Infection

NCT00002214 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetic Study of the Vaginal Microbicide Agent 1% Tenofovir Gel

NCT00561496 ·Status: COMPLETED ·Phase: PHASE1

A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior Therapy

NCT00053638 ·Status: COMPLETED ·Phase: PHASE3

A Multicenter, Open-Label, Randomized, 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate, 800 Mg q 8 h Versus 1,200 Mg q 12 h in Combination With Zidovudine and 3TC

NCT00002208 ·Status: COMPLETED ·Phase: PHASE3

Healthy Volunteer Study To Assess The Bioavailability of GSK1265744 When Administered Orally Either When Fasted or Following a Meal.

NCT00812318 ·Status: COMPLETED ·Phase: PHASE1

Sustiva Levels With Use of a Gel Capsule

NCT01087814 ·Status: COMPLETED ·Phase: PHASE4

Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) Infection

NCT01386294 ·Status: COMPLETED ·Phase: PHASE3

Part A: Drug Interaction Study of Sofosbuvir and Antiretroviral Therapy (ART) Combinations in HIV and Hepatitis C Virus (HCV) Co-infected Patients. Part B: Efficacy and Safety of Sofosbuvir for 12 Weeks in HIV/HCV Co-infected Patients.

NCT01565889 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety and Effectiveness of TFV 1% Gel, TDF Tablets, and FTC/TDF Tablets in Preventing HIV in Women

NCT00705679 ·Status: COMPLETED ·Phase: PHASE2

Adherence and Acceptability to and Blood Levels of Tenofovir Gel and Tablets in HIV Uninfected Women

NCT00592124 ·Status: COMPLETED ·Phase: PHASE2

A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Two Different Formulations of Long-acting Cabotegravir in Healthy Adult Participants

NCT06033547 ·Status: COMPLETED ·Phase: PHASE1